SALEM INVESTMENT COUNSELORS INC

Position in HLN — Haleon plc

CIK 884423 WINSTON-SALEM, NC

Position in HLN

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$91,231

+$69,605 QoQ

Shares Held

9,114

+278.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 26.453807329383366.ToString("F0")% Shared 0.ToString("F0")% None 73.54619267061663.ToString("F0")%

Healthcare · as of Mar 31, 2026

SALEM INVESTMENT COUNSELORS INC holds $527,346 across 13 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (17.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	16,696	$225,562
2	HLN	Haleon plc This page	9,114	$91,231
3	ZTS	Zoetis Inc.	586	$69,271
4	DERM	Journey Medical Corp	14,300	$67,067
5	HROW	Harrow, Inc.	1,300	$45,838
6	HIMS	Hims & Hers Health, Inc.	1,025	$21,279
7	TLRY	Tilray Brands, Inc.	331	$2,141
8	BCRX	Biocryst Pharmaceuticals Inc	200	$1,904

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$91,231	9,114	+278.0%	Shares	Sole	2026-04-29
2025-09-30	$21,626	2,411	0.0%	Shares	Sole	2025-10-07
2025-06-30	$25,002	2,411	-20.2%	Shares	Sole	2025-07-08
2025-03-31	$31,106	3,023	+25.4%	Shares	Sole	2025-04-16
2024-12-31	$23,000	2,411	-8.3%	Shares	Sole	2025-01-13
2024-09-30	$27,804	2,628	+0.7%	Shares	Sole	2024-10-15
2024-06-30	$21,566	2,611	-11.8%	Shares	Sole	2024-07-11
2024-03-31	$25,138	2,961	+13.4%	Shares	Sole	2024-04-11
2023-12-31	$21,488	2,611	+2.0%	Shares	Sole	2024-01-16
2023-09-30	$21,333	2,561	0.0%	Shares	Sole	2023-10-04
2023-06-30	$21,461	2,561	0.0%	Shares	Sole	2023-07-19
2023-03-31	$20,846	2,561	-12.8%	Shares	Sole	2023-05-11
2022-12-31	$23,488	2,936	-54.5%	Shares	Sole	2023-02-15
2022-09-30	$39,329	6,458	—	Shares	Sole	2022-11-09
No filing history on record for this holder in this stock.